https://www.avient.com/sites/default/files/2023-01/Mevopur Standard Colors Product Bulletin _ Color Card.pdf
Concentrates and pre-colored formulations are available for a wide range of polymers, including PE, PP, PEBA, PC, ABS, and others.
KEY CHARACTERISTICS • Globally harmonized formulations are manufactured at four ISO 13485 certified medical sites, providing global consistency and increased security of supply • Documented change control available • A range of standard colors eliminates color matching to expedite development time • The portfolio includes compliant colors for use in: - Needle hub applications: ISO 6009 - Ophthalmic container closures (American Academy of Ophthalmology) REGULATORY SUPPORT • A library of pre-tested raw materials including: - ISO 10993-1 and USP biological evaluation - European Pharmacopeia 3.1.3/3.1.5 (polyolefin) - USP (polyethylene) - ICH Q3D elemental impurities • Registered Drug Master File (Type III) and/or Device Master File • Food contact established with FDA/EU* HEALTHCARE APPLICATIONS • Medical devices such as catheters, surgical and dental instruments, and drug delivery devices • Pharmaceutical packaging including vials and bottles • Diagnostics for blood analysis or In Vitro Diagnostics (IVD) PRODUCT BULLETIN & COLOR CARD * FDA/EU compliance information available upon request; exceptions may occur Color Pantone Reference PE Base PP Base Transparent PP Base PEBA Base PC Base Transparent PC Base* ABS Base* White — PE0M176031 PP0M176045 ** AH0M415001 NC0M176058 ** SB0M665206 Yellow 102C PE1M176076 PP1M176060 PP1M176062 AH1M415002 NC1M176058 NC1M176059 SB1M664958 Orange 158C PE2M176044 PP2M176046 ** ** NC2M176044 NC2M664912 SB2M664939 Red 199C PE3M176131 PP3M176111 PP3M176113 AH3M415002 NC3M176116 NC3M176122 SB3M665037 Pink 196C PE3M176130 PP3M176109 ** AH3M415001 NC3M176117 NC3M665052 SB3M665039 Violet 2593C PE4M176023 PP4M176036 PP4M176039 AH4M415001 NC4M176038 NC4M176044 SB4M664978 Light Blue 292C PE5M176155 PP5M176169 ** AH5M415003 NC5M176142 ** SB5M665402 Mid Blue 285C PE5M176154 PP5M176171 PP5M176175 AH5M415002 NC5M176143 NC5M176146 SB5M665404 Dark Blue 288C PE5M176153 PP5M176173 ** ** NC5M176144 ** SB5M665406 Light Green 346C PE6M176128 PP6M176111 ** ** NC6M176118 ** SB6M665070 Bluish Green 3145C PE6M176126 PP6M176115 ** ** NC6M176119 ** SB6M665068 Medium Green 348C PE6M176127 PP6M176113 PP6M176118 AH6M415001 NC6M176120 NC6M176121 SB6M665072 Dark Gray 425C PE7M176066 PP7M176091 PP7M176094 ** NC7M176124 ** SB7M665297 Mid Gray Cool Gray 5C PE7M176067 PP7M176089 ** AH7M415001 NC7M176125 NC7M665175 SB7M665295 Beige 7502C PE8M176048 PP8M176058 ** ** NC8M176058 ** SB8M664871 Brown 463C/731C PE8M176049 PP8M176060 ** ** NC8M176059 ** SB8M664869 Black Black C PL9M176008 PP9M176017 ** ** NC9M176008 NC9M176009 SB9M664896 Colors may vary from actual color shown.
https://www.avient.com/sites/default/files/2022-12/Mevopur Colors for Ophthalmic Closures Application Bulletin_A4.pdf
This portfolio is based on a PE carrier, but can be provided in a PP carrier on request.
KEY CHARACTERISTICS • Manufactured at four ISO 13485 certified manufacturing sites, providing global consistency and increased security of supply • Documented change control beyond CAS number, reducing risk of change • Non-phthalate and formulated without animal- derived substances • Standard concentrates in a PE carrier and on request in PP • Pre-colored formulations can be supplied in specific resins selected for the application REGULATORY SUPPORT • Raw materials tested to: - ISO 10993-1 and USP biological evaluation - European Pharmacopeia 3.1.3/3.1.5 (polyolefin) - USP (polyethylene) - ICH Q3D elemental impurities • Registered Drug Master File (Type III) • Food contact established with FDA/EU* APPLICATION BULLETIN DRUG TYPE COLOR DESCRIPTION PANTONE REFERENCE AVIENT PRODUCT CODE PE BASED Adrenergic agonist combinations Light Green 373 C PE6M176349 Adrenergic agonists Purple 2583 C PE4M176057 Anti-infectives Tan 467 C PE8M176130 Anti-inflammatory, nonsteroidal Grey Cool Grey 4 C PE7M176184 Anti-inflammatory, steroids Pink 197 C PE3M176237 Anti-inflammatory, immunomodulators Olive Green 5763 C On request Beta-blockers Yellow Yellow C PE1M176160 Beta-blocker combinations Dark Blue 281 C PE5M176272 Carbonic anhydrase inhibitors Orange 1585 C PE2M176089 Cytotoxic Black 6 C PL9M176008 Miotics Dark Green 348 C PE6M176267 Mydriatics and cycloplegics Red 1797 C PE3M176236 Prostaglandin analogues Turquoise 326 C PE5M176273 Healthcare use limitations apply—see below.
For containers/bottles, Avient also offers Remafin™ EP White Colorants, available in low density and high density PE and PP resins.
https://www.avient.com/sites/default/files/2023-10/Cesa Unify A4R Product Bulletin.pdf
For this reason packaging often contains layers of both PP and PE based on its functionality.
It works by bringing incompatible polymers – such as PP and PE – together by forming them into a homogenous polymer mixture that increases mechanical properties based on polymer modification.
This literature shall NOT operate as permission, recommendation, or inducement to practice any patented invention without permission of the patent owner. 1.844.4AVIENT www.avient.com KEY CHARACTERISTICS • Designed for polyolefin recycling and to enhance circularity • Helps bring incompatible polymers together by forming them into a homogenous polymer mixture • Improves the mechanical performance of mixed PP/PE streams • Increases impact strength by up to 50% • Increases ductility by up to 100% for improved performance • Maintains mechanical strength properties close to polymer starting point • The end result is that the characteristics of rPP remain with higher impact properties • Good cost-performance ratio • Can be combined with color into a single masterbatch product for convenience • Product guidance and technical assistance is available from our experts MARKETS & APPLICATIONS • Recycled polyolefins • Packaging, consumer & others • High-value polyolefin applications with recycled material content • Virgin polymers which will be recycled after the use phase Currently unavailable in North America—please contact your Avient representative for further information.
https://www.avient.com/sites/default/files/2025-06/LFT Brackets Application Bulletin.pdf
• Complēt™ long glass, long carbon, and hybrid fiber solutions available in a wide array of engineering polymer matrices, including PA66, PA6, ETPU, PPA, PPS, PES, PEI, PK, and PEEK • OnForce™ long glass fiber reinforced polypropylenes • Full suite of design and engineering services that include structural design and fiber orientation consultations and modeling, CAE analysis, prototyping, and more STRENGTH-TO-WEIGHT RATIO OF LFT VS METALS m eg ap as ca l gram /cubic centim eter 250 200 150 100 50 0 9.00 8.00 7.00 6.00 5.00 4.00 3.00 2.00 1.00 0.00 Zam ak 3 Stainless Steel 304 Titanium #2 Com plēt LCF40-PP Com plēt LGF60-TPU OnForce LGF50-PP Alum inum A380 M agnesium AZ91D Com plēt LCF50-PA66 Com plēt LGF60-PA66 Com plēt LCF50-TPU Specific Strength Density Metal Long Glass Fiber Long Carbon Fiber 1.844.4AVIENT www.avient.com Copyright © 2025, Avient Corporation.
https://www.avient.com/sites/default/files/2023-08/Hydrocerol Chemical Foaming Agents - PP Door Panel - Application Snapshot 2.pdf
https://www.avient.com/sites/default/files/resources/Investor%2520Day%2520-%2520May%25202012%2520-%2520Critical%2520Imperatives.pdf
Page 102 Critical Imperatives – Medium to Long Term • Continue cultural and paradigm shift from commodity compounder to collaborative formulator as One PolyOne • Accelerate innovation and leverage megatrends to improve our mix of business with higher-margin improve our mix of business with higher-margin specialty products • Increase specialty contribution and advance globalization via acquisitions • Drive relentless execution and creative innovation as key competitive differentiators Page 103 2011 Proforma ColorMatrix 2015 Target “Where we are” “Where we expect to be” 1) Operating Income % Specialty 8.9% PP&S 7.2% 12 – 16% 9 – 12% Elevating our Expectations and Yours PP&S 7.2% Distribution 5.6% 2) Specialty Platform % of Operating Income 50% 3) ROIC* (after-tax) 10% 4) Adjusted Annual EPS Growth 3 yr CAGR = 71% 9 – 12% 6 – 7.5% 65 – 75% 15% Double Digit Expansion *ROIC is defined as TTM adjusted OI divided by the sum of average debt and equity over a 5 quarter period Page 104
https://www.avient.com/sites/default/files/2021-10/versaflex-top-cover-of-air-cushion-powder-case-study-one-pager.pdf
Cosmetic brands COSMETIC BRANDS C O V E R O F A I R C U S H I O N P O W D E R C O M P A C T • Low coefficient of friction (COF) to balance the opening pressure and sealing performance • General FDA compliance • Good chemical resistance and barrier protection to water and oxygen • Overmold to PP with good compression set • Delivered chemically resistant material with excellent sealing properties and good resilience to achieve requested performance • Provided onsite technical support to improved injection speed and achieve good bonding performance • Offered a material solution that could be leveraged across the customer’s global cosmetic brands Custom Versaflex™ TPE KEY REQUIREMENTS WHY AVIENT?
https://www.avient.com/sites/default/files/2024-07/CCG Application Snapshot Evoluscend Mold Release_Final.pdf
PowerPoint Presentation M E D I C A L C O N N E C T O R S • Ongoing production with no change to regular set up • Excellent processing and demolding performance • Color stability during processing • Excellent chemical and impact resistance • Enabled efficient ongoing production rates without changing any processing parameters • Safeguarded color stability and transparency during processing for optimal aesthetics • Ensured regulatory requirements for biocompatible ISO109931 and FDA were met • Provided a solution effective across a range of high-temperature polymers, including PEEK, PPSU, PES, PSU, PEI, LCP, and PPS Colorant Chromatics Evoluscend non- PFAS* high-temperature polymer mold release additive KEY REQUIREMENTS WHY AVIENT AVIENT SOLUTION PRODUCTIVITY + REGULATORY LEARN MORE ELECTRICAL COMPONENT OEM (*) A non-PFAS additive manufactured without non-intentionally added (NIA) PFAS or PTFE. (*) manufactured without intentionally added PFAS and without PTFE (1) refers to sulfone products only https://www.avient.com/products/polymer-additives/processing-enhancement-additives/colorant-chromatics-evoluscend-non-pfas-high-temperature-mold-release-additive Slide Number 1
https://www.avient.com/sites/default/files/resources/Investor%2520Day%2520-%2520May%25202012%2520-%2520Summary%2520and%2520QA.pdf
Newlin Page 105 Old PolyOne Transformation 60% 80% 100% % o f O p e ra ti n g I n co m e * Mix Shift Highlights Specialty Transformation Ahead of Schedule 2015 Target *Operating Income excludes Corporate Charges ** Pro Forma for the acquisition of ColorMatrix and divestiture of SunBelt 2% 34% 42% 50% 65-75% 0% 20% 40% 2005 2008 2011 2011** 2015 % o f O p e ra ti n g I n co m e * JV's PP&S Distribution Specialty Specialty OI $5M $46M $89M $117M Target Page 106 Why Invest In PolyOne?
https://www.avient.com/sites/default/files/2021-03/wet-grip-tpe-surfco-wax-mat-case-study-one-pager.pdf
W A X M A T ® G R I P T A P E • Provide alternative material to traditional wax and EVA foam for grip on surfboards • Translucent appearance • Coextrude with polypropylene (PP) film • Excellent UV resistance • Customized formulation for exceptional hydrophobic grip and non-abrasive finish • Incorporated specialty additives to enhance UV resistance and inhibit mold growth • Solved technical processing challenges to achieve efficient coextrusion of materials and achieve optimal bonding to adhesive backing • Enabled customer to achieve market differentiation and expand into new markets and applications Custom GLS™ TPE Wet Grip Formulation KEY REQUIREMENTS WHY AVIENT?